Patients with rheumatoid arthritis
and other inflammatory diseases are at increased risk for developing infections like shingles
. Many of these patients take immunosuppressive drugs to treat the inflammation and pain associated with those diseases. A new study examined whether patients beginning anti-T-N-F therapy
are at a higher risk for developing shingles infection. Catherine Dolf explains in this week’s JAMA Report.
Source: Association Between the Initiation of Anti–Tumor Necrosis Factor Therapy and the Risk of Herpes Zoster